Literature DB >> 21741455

Alzheimer's disease: cholesterol a menace?

Anila Mathew1, Yasuhiko Yoshida, Toru Maekawa, D Sakthi Kumar.   

Abstract

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease manifested by cognitive and memory deterioration, culminating in a spectrum of neuropsychiatric disturbances and the impairment of daily activities. AD is a multifactorial disease with a range of contributing factors which includes genes and diet. The magnitude of AD is reflected in the loss of individuality of the affected person and in the terminal course through which the disease develops. In this review, we aim to provide a background on AD and the contribution of cholesterol in the etiology of Alzheimer's. Cholesterol seems to be intimately linked with the generation of amyloid plaques, which is central to the pathogenesis of AD. Although there are conflicting reports on the role of cholesterol in AD, majority of the studies point out the positive association of cholesterol with AD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741455     DOI: 10.1016/j.brainresbull.2011.06.006

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

1.  Alzheimer's disease: brain desmosterol levels.

Authors:  Thomas Wisniewski; Kia Newman; Norman B Javitt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; A Scott Winter; Meharvan Singh; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; Rebecca Cunningham; Meharvan Singh; Sid E O'Bryant
Journal:  Dement Geriatr Cogn Disord       Date:  2014-07-04       Impact factor: 2.959

4.  Characterization of a normal control group: are they healthy?

Authors:  C J Aine; L Sanfratello; J C Adair; J E Knoefel; C Qualls; S L Lundy; A Caprihan; D Stone; J M Stephen
Journal:  Neuroimage       Date:  2013-09-20       Impact factor: 6.556

5.  Nonlinear longitudinal trajectories of cholesterol and neuropsychological function.

Authors:  Carrington R Wendell; Shari R Waldstein; Alan B Zonderman
Journal:  Neuropsychology       Date:  2013-11-04       Impact factor: 3.295

6.  Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.

Authors:  David A Hicks; Natalia N Nalivaeva; Anthony J Turner
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

Review 7.  Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.

Authors:  Theoharis C Theoharides; Julia M Stewart; Erifili Hatziagelaki; Gerasimos Kolaitis
Journal:  Front Neurosci       Date:  2015-07-03       Impact factor: 4.677

8.  Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.

Authors:  Feng Bai; Yonggui Yuan; Yongmei Shi; Zhijun Zhang
Journal:  Oncotarget       Date:  2016-03-29

Review 9.  Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease.

Authors:  Ernest Dallé; Musa V Mabandla; William M U Daniels
Journal:  Oxid Med Cell Longev       Date:  2020-02-13       Impact factor: 6.543

Review 10.  PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease.

Authors:  Sanaz Keshavarz Shahbaz; Khadijeh Koushki; Thozhukat Sathyapalan; Muhammed Majeed; Amirhossein Sahebkar
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.